Advertisement
Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

TPI Board Reinstates Stock Repurchase Program

June 3, 2011 5:36 am | News | Comments

CHENGDU, China, June 3, 2011 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI ), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and other pharmaceuticals today...

CIO magazine Honors Life Technologies for Leadership in Information Technology

June 3, 2011 5:36 am | News | Comments

CARLSBAD, Calif., June 3, 2011 /- Life Technologies Corporation (NASDAQ: LIFE ) has been honored by IDG's CIO magazine as a part of the 2011 CIO 100 , an annual award program that recognizes organizations around the world that exemplify the highest level of operational and strategic...

DURECT to Present at the Jefferies Healthcare Conference

June 3, 2011 5:36 am | News | Comments

CUPERTINO, Calif., June 3, 2011 /- DURECT Corporation (Nasdaq: DRRX ) announced today that Jim Brown, President and CEO, will be presenting at the Jefferies Healthcare Conference on Tuesday, June 7 at 4:30 p.m. Eastern time.  The conference is being held at the Grand Hyatt in New...

Advertisement

Echo Therapeutics to Present at the Jefferies 2011 Global Healthcare Conference

June 3, 2011 5:36 am | News | Comments

PHILADELPHIA, June 3, 2011 /- Echo Therapeutics, Inc. (OTCBB: ECTE), a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude™ SkinPrep System for transdermal drug delivery, today...

Orexigen® Therapeutics Provides a Regulatory Update on Contrave® NDA

June 3, 2011 3:32 am | News | Comments

SAN DIEGO, June 3, 2011 /- Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) announced today that it recently met with the Food and Drug Administration (FDA) regarding the New Drug Application for Contrave® (naltrexone HCl/bupropion HCl) extended-release tablets for the treatment of...

Thermographic Imaging Systems for Breast Cancer Screening: FDA Safety Communication

June 2, 2011 2:30 pm | News | Comments

Thermography is not a replacement for screening mammography and should not be used by itself to diagnose breast cancer.

MD Anderson and Biocept Scientists to Present Poster at ASCO on Disseminated Tumor Cells (DTCs) in Bone Marrow and Circulating Tumor Cells (CTCs) in Blood in Early Stage Breas...

June 2, 2011 1:34 pm | News | Comments

SAN DIEGO, June 2, 2011 /- Data to be presented in a poster at the 2011 Annual Meeting of the American Society of Clinical Oncology (ASCO) taking place in Chicago, Illinois June 3-7 by researchers from The University of Texas MD Anderson Cancer Center and Biocept, Inc. show that a...

Spherix Drug Candidate SPX-106 Shows Statistically Significant Reductions in Serum Triglycerides in Preclinical Testing

June 2, 2011 1:34 pm | News | Comments

BETHESDA, Md., June 2, 2011 /- Spherix Incorporated (NASDAQ: SPEXD) -- an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical...

Advertisement

Biocept and Academic Collaborators to Present Poster at ASCO on Circulating Tumor Cells (CTCs)

June 2, 2011 1:33 pm | News | Comments

SAN DIEGO, June 2, 2011 /- Biocept, Inc. today reported that its scientists and academic collaborators will present a poster at the 2011 Annual Meeting of the American Society of Clinical Oncology (ASCO) taking place in Chicago, Illinois June 3-7. The poster presentation is based on...

Caring for caregivers

June 2, 2011 1:33 pm | News | Comments

An ASU psychologist develops interventions for people taking care of loved ones with dementia.read more

Manufacturer of Motors, Powered Surgical Devices, Motion Control Products

June 2, 2011 12:36 pm | Pro-Dex | Product Releases | Comments

Established in 1975, Pro-Dex Inc. has grown to specialize in the design, development and contract manufacture of everything from components, motors and subassemblies to complete powered surgical devices.

Masimo Initiates Limited Market Release of E1, Single-Patient-Use Ear Sensor for Pulse Oximetry Monitoring

June 2, 2011 12:34 pm | News | Comments

IRVINE, Calif., June 2, 2011 /- Masimo (NASDAQ: MASI ) announced today FDA 510(k) Clearance, CE Mark, and limited market release of the industry's first single-patient-use ear sensor.  Compared to digit sensors, the Masimo E1™ enables faster detection of oxygen saturation...

Medco Partners With MolecularMD on Personalized Medicine Program for Chronic Myeloid Leukemia

June 2, 2011 12:32 pm | News | Comments

FRANKLIN LAKES, N.J. and PORTLAND, Ore., June 2, 2011 /- Medco Health Solutions, Inc. (NYSE: MHS ) and MolecularMD Corp. today announce the launch of a personalized medicine program for chronic myeloid leukemia (CML) patients.  Through this program, Medco will offer patients...

Advertisement

FDA Safety Communication: Breast Cancer Screening - Thermography is Not an Alternative to Mammography

June 2, 2011 12:30 pm | News | Comments

The FDA is issuing this communication to alert the public, including women and health care providers, that thermography is not a replacement for screening mammography and should not be used by itself to diagnose breast cancer. The FDA is not aware of any

Covidien's hernia mesh gets U.S. and European OK

June 2, 2011 10:34 am | News | Comments

Covidien plc has won approval in both the U.S. and Europe to market its Parietex Optimized Composite (PCOx) mesh used in surgical hernia repair, the company said today.

Siemens Healthcare PACS Certifies BridgeHead Software

June 2, 2011 10:34 am | News | Comments

BridgeHead MediStore™ proven to offer a comprehensive medical imaging archive with full disaster recovery capabilities for Siemens SYNGO usersASHTEAD, UK AND WOBURN, MA - June 02, 2011 - BridgeHead Software, a leader in healthcare data and storage management, today announced the...

Kaiser Permanente Colorado Receives Top Honor for Excellence in Medication Safety

June 2, 2011 9:35 am | News | Comments

DENVER, June 2, 2011 /- Kaiser Permanente Colorado is one of only three health plans in the nation to receive a top honor for excellence in medication safety. The award, issued by the Pharmacy Quality Alliance, recognizes Kaiser Permanente's outstanding performance on medication safety...

PQA Recognizes Kaiser Permanente Hawaii for Excellence in Medication Safety

June 2, 2011 9:35 am | News | Comments

HONOLULU, June 2, 2011 /- Kaiser Permanente Hawaii has received the inaugural Pharmacy Quality Alliance (PQA) Quality Award.  This award recognizes Kaiser Permanente's achievement of a 5-star rating on the PQA measures of medication safety that are included in the Centers for...

Benchmark Electronics Recognized as Supplier for 2011 Design Medical Excellence Award Winner in the Radiological and Electromechanical Devices Category

June 2, 2011 9:34 am | News | Comments

ANGLETON, Texas, June 2, 2011 /- Benchmark Electronics, Inc. (NYSE: BHE ), a leading integrated contract manufacturing provider, announced today that a product it helped commercialize and currently manufactures has won a 2011 Medical Design Excellence Awards. The Avedro Vedera KXS Vision...

FDA: Treatment With Angiotensin Receptor Blockers for High Blood Pressure Does Not Increase Risk of Cancer

June 2, 2011 9:33 am | News | Comments

SILVER SPRING, Md., June 2, 2011 /PRNewswire-USNewswire/ --The U.S. Food and Drug Administration today announced that a group of medications used to control high blood pressure, called angiotensin receptor blockers (ARBs), do not increase the risk of developing cancer in patients using...

Mylan Receives Approval for Generic Version of Effexor XR® Capsules

June 2, 2011 9:32 am | News | Comments

PITTSBURGH, June 2, 2011 /- Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Venlafaxine Hydrochloride (HCl)...

Commencement of GMP Production Project for Lead Anti-Cancer Product PAT-LM1

June 2, 2011 9:32 am | News | Comments

MELBOURNE, Australia and PRINCETON, N.J., June 2, 2011 /- Patrys Limited (ASX: PAB) (the "Company"), a biopharmaceutical company focused on the development of novel treatments for cancer, is pleased to announce it has extended its relationship with Laureate Biopharmaceutical Services,...

MedInformatix RIS Enhances Lenox Hill Radiology's Practice Management Efficiencies for Better Workflow and Improved Customer Service

June 2, 2011 8:32 am | News | Comments

NEW YORK, June 2, 2011 /- Lenox Hill Radiology is first in its field with respect to leveraging cutting-edge technology to provide a full scope of diagnostic radiology services and care to patients, as well as to New York-area physicians, healthcare practitioners, hospitals, universities...

Vanda Pharmaceuticals to Present at the Jefferies 2011 Global Healthcare Conference

June 2, 2011 7:33 am | News | Comments

ROCKVILLE, Md., June 2, 2011 /- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ), a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders, today announced that Mihael H. Polymeropoulos, M.D., Vanda President and CEO...

IDEV Technologies Announces Completion of SUPERB Clinical Trial Enrollment

June 2, 2011 6:35 am | News | Comments

WEBSTER, Texas, June 2, 2011 /- IDEV Technologies, Inc. (IDEV) today announced the completion of enrollment in the SUPERB Trial, an FDA-approved IDE trial evaluating the use of IDEV's SUPERA® stent system for treatment of peripheral artery disease in the superficial femoral artery...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading